Analysts Viewpoint
A Guide To The Risks Of Investing In AIM ImmunoTech Inc (AIM)
AIM ImmunoTech Inc’s recently made public that its Director BRYAN NANCY acquired Company’s shares for reported $15000.0 on Mar 21
Menu
AIM ImmunoTech Inc’s recently made public that its Director BRYAN NANCY acquired Company’s shares for reported $15000.0 on Mar 21
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
U.S. stocks continued their slide yesterday with all three major indices closing in the red. The Dow was the biggest